The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding

Archives of General Psychiatry

Volumn 68, Issue 9, 2011, Pages 892-900

  Murrough, James W ^a   Czermak, Christoph ^b   Henry, Shannan ^b   Nabulsi, Nabeel ^c   Gallezot, Jean Dominique ^c   Gueorguieva, Ralitza ^d   Planeta Wilson, Beata ^c   Krystal, John H ^d   Neumaier, John F ^e   Huang, Yiyun ^c   Ding, Yu Shin ^c   Carson, Richard E ^c   Neumeister, Alexander ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Positron Emission Tomography Center   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; RADIOLIGAND; SEROTONIN 1B RECEPTOR; TRACER;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; CAUDATE NUCLEUS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IN VIVO STUDY; INJURY; LIGAND BINDING; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS OF VARIANCE; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; RADIOASSAY; RECEPTOR BINDING; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGE FACTORS; BRAIN; CARBON RADIOISOTOPES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; PYRROLIDINONES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; STRESS DISORDERS, POST-TRAUMATIC; TRAUMA SEVERITY INDICES; WOUNDS AND INJURIES;

EID: 80052516581     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.91     Document Type: Article

References (88)

1. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 1995;52 (12):1048-1060.
2. Charney D.S. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. Am J Psychiatry. 2004; 161(2):195-216. (Pubitemid 38419269)
3. Krystal J.H., Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res. 2009; 1293:13-23.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
5. Breslau N., Davis G.C., Andreski P., Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 1991;48(3):216-222.
6. Horowitz M.J., Wilner N., Kaltreider N., Alvarez W. Signs and symptoms of posttraumatic stress disorder. Arch Gen Psychiatry. 1980;37(1):85-92. (Pubitemid 10179616)
7. Bremner J.D., Southwick S.M., Johnson D.R., Yehuda R., Charney D.S. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry. 1993;150(2):235-239. (Pubitemid 23046508)
8. Silva R.R., Alpert M., Munoz D.M., Singh S., Matzner F., Dummit S. Stress and vulnerability to posttraumatic stress disorder in children and adolescents. Am J Psychiatry. 2000;157(8):1229-1235. (Pubitemid 30659805)
9. Widom C.S. Posttraumatic stress disorder in abused and neglected children grown up. Am J Psychiatry. 1999;156(8):1223-1229. (Pubitemid 29374883)
10. Stein D.J., Ipser J.C., Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;(1):CD002795. doi:10.1002 /14651858.CD002795.pub2.
11. Berger W., Mendlowicz M.V., Marques-Portella C., Kinrys G., Fontenelle L.F., Marmar C.R., Figueira I. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A Systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):169-180.
12. Chaouloff F., Berton O., Mormède P. Serotonin and stress. Neuropsychopharmacology. 1999;21(2)(suppl):28S-32S. (Pubitemid 29396468)
13. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev. 1993;18(1):1-32. (Pubitemid 23090009)
14. SteinbuschH.W.M.Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience. 1981;6(4):557-618. (Pubitemid 11102583)
15. Southwick S.M., Krystal J.H., Bremner J.D., Morgan C.A. III, Nicolaou A.L., Nagy L.M., Johnson D.R., Heninger G.R., Charney D.S. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry. 1997;54(8):749-758. (Pubitemid 27344103)
16. Davis L.L., Clark D.M., Kramer G.L., Moeller F.G., Petty F. D-fenfluramine challenge in posttraumatic stress disorder. Biol Psychiatry. 1999;45(7):928-930. (Pubitemid 29185485)
17. Corchs F., Nutt D.J., Hood S., Bernik M. Serotonin and sensitivity to traumarelated exposure in selective serotonin reuptake inhibitors - Recovered posttraumatic stress disorder. Biol Psychiatry. 2009;66(1):17-24.
18. Charney D.S., Goodman W.K., Price L.H., Woods S.W., Rasmussen S.A., Heninger G.R. Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan andm-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry. 1988;45(2):177-185. (Pubitemid 18052850)
19. Krystal J.H., Webb E., Cooney N.L., Kranzler H.R., Southwick S.W., Heninger G.R., Charney D.S. Serotonergic and noradrenergic dysregulation in alcoholism: Mchlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry. 1996;153(1):83-92.
20. Price L.H., Malison R.T., McDougle C.J., McCance-Katz E.F., Owen K.R., Heninger G.R. Neurobiology of tryptophan depletion in depression: Effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology. 1997;17(5):342-350. (Pubitemid 27468171)
21. Brady K., Pearlstein T., Asnis G.M., Baker D., Rothbaum B., Sikes C.R., Farfel G.M. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA. 2000;283(14):1837-1844. (Pubitemid 30207620)
22. Davidson J.R.T., Rothbaum B.O., Van der Kolk B.A., Sikes C.R., Farfel G.M. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58(5):485-492. (Pubitemid 32411330)
23. Marshall R.D., Beebe K.L., Oldham M., Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-1988. (Pubitemid 33104102)
24. Tucker P., Zaninelli R., Yehuda R., Ruggiero L., Dillingham K., Pitts C.D. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebocontrolled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-868. (Pubitemid 33131172)
25. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 1994;33(3-4):275-317. (Pubitemid 24168700)
26. Bonne O., Bain E., Neumeister A., Nugent A.C., Vythilingam M., Carson R.E., Luckenbaugh D.A., Eckelman W., Herscovitch P., Drevets W.C., Charney D.S. No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am J Psychiatry. 2005;162(2):383-385. (Pubitemid 40216222)
27. 1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev. 2004;28(6):565-582.
28. Ruf B.M., Bhagwagar Z. The 5-HT1B receptor: A novel target for the pathophysiology of depression. Curr Drug Targets. 2009;10(11):1118-1138.
29. 1B receptor stimulation in the rat elevated plus-maze. Pharmacol Biochem Behav. 2002;71(4):581-587.
30. Critchley M.A., Handley S.L. Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology (Berl). 1987;93(4):502- 506.
31. Benjamin D., Lal H., Meyerson L.R. The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci. 1990;47(3):195-203. (Pubitemid 20243798)
32. 1B receptor in dorsal raphe nucleus using herpes simplex virus gene transfer increases anxiety behavior after inescapable stress. J Neurosci. 2002; 22(11):4550-4562.
33. 1B receptor in dorsal raphe nucleus decreases fear-potentiated startle in a stress dependent manner. Brain Res. 2004;1007(1-2):86-97.
34. Bolanos-Jimenez F., Manhaes de Castro R.M., Seguin L., Cloez-Tayarani I., Monneret V., Drieu K., Fillion G. Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur J Pharmacol. 1995;294(2-3): 531-540. (Pubitemid 26016760)
35. Bibancos T., Jardim D.L., Aneas I., Chiavegatto S. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice. Genes Brain Behav. 2007;6(6):529-539. (Pubitemid 47246219)
36. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169-191.
37. Phan K.L., Wager T., Taylor S.F., Liberzon I. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002; 16(2):331-348. (Pubitemid 34852450)
38. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry. 2003;54 (5):515-528. (Pubitemid 37289438)
39. Shin L.M., Orr S.P., Carson M.A., Rauch S.L.,Macklin M.L., Lasko N.B., Peters P.M.,Metzger L.J., Dougherty D.D., Cannistraro P.A., Alpert N.M., Fischman A.J., Pitman R.K. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry. 2004;61(2):168-176. (Pubitemid 38146551)
40. Liberzon I., Taylor S.F., Amdur R., Jung T.D., Chamberlain K.R., Minoshima S., Koeppe R.A., Fig L.M. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry. 1999;45(7):817-826. (Pubitemid 29188020)
41. Taylor S.F., Liberzon I. Neural correlates of emotion regulation in psychopathology. Trends Cogn Sci. 2007;11(10):413-418. (Pubitemid 47588995)
42. 11C]P943. Nucl Med Biol. 2010;37(2):205-214.
43. Yehuda R., Flory J.D., Pratchett L.C., Buxbaum J., Ising M., Holsboer F. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl). 2010;212(3):405- 417.
44. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis Disorders (SCID). New York: New York State Psychiatric Institute, Biometrics Research; 1995.
45. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., Keane T.M. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90.
46. Kubany E.S., Haynes S.N., Leisen M.B., Owens J.A., Kaplan A.S., Watson S.B., Burns K.Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: The Traumatic Life Events Questionnaire. Psychol Assess. 2000; 12(2):210-224.
47. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1):50-55.
48. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. (Pubitemid 9136500)
49. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
50. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Harcourt Assessment; 1999.
51. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using amacroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273-289. (Pubitemid 34852226)
52. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23(9):1096-1112.
53. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S-C, Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533-1539. (Pubitemid 47301451)
54. 1B receptor mRNA in the human brain. Synapse. 2005;56(1):21-28.
55. 11C]P943 in humans. J Cereb Blood Flow Metab. 2010;30(1):196-210.
56. Brewin C.R., Andrews B., Valentine J.D. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000; 68(5):748-766.
57. Nishith P., Mechanic M.B., Resick P.A. Prior interpersonal trauma: The contribution to current PTSD symptoms in female rape victims. J Abnorm Psychol. 2000; 109(1):20-25. (Pubitemid 30155402)
58. Cloitre M., Scarvalone P., Difede J.A. Posttraumatic stress disorder, self- and interpersonal dysfunction among sexually retraumatized women. J Trauma Stress. 1997;10(3):437-452. (Pubitemid 27316409)
59. Lang A.J., Aarons G.A., Gearity J., Laffaye C., Satz L., Dresselhaus T.R., Stein M.B. Direct and indirect links between childhood maltreatment, posttraumatic stress disorder, and women's health. Behav Med. 2008;33(4):125-135.
60. Meewisse M-L, Reitsma J.B., De Vries G-J, Gersons B.P.R., Olff M. Cortisol and posttraumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry. 2007;191:387-392. (Pubitemid 350069578)
61. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science. 2004;306(5697): 879-881. (Pubitemid 39446998)
62. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci. 2008;28(1):199-207.
63. Bonaventure P., Schotte A., Cras P., Leysen J.E. Autoradiographic mapping of 5-HT1Band 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand. Receptors Channels. 1997;5(3-4):225-230. (Pubitemid 28242961)
64. Boulenguez P., Segu L., Chauveau J., Morel A., Lanoir J., Delaage M. Biochemical and pharmacological characterization of serotonin-O- carboxymethylglycyl[125l]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites. J Neurochem. 1992;58(3):951-959.
65. 3H]GR 125743. Brain Res. 2001;915(1):47-57.
66. 1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience. 1999;88(3):899-915.
67. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain, I: Serotonin-1 receptors. Brain Res. 1985;346(2):205-230. (Pubitemid 16241111)
68. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986; 9:357-381. (Pubitemid 16055790)
69. Koolschijn P.C.M.P., Van Haren N.E.M., Lensvelt-Mulders G.J.L.M., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: A metaanalysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009;30 (11):3719-3735.
70. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010;35(1):192-216.
71. Lucey J.V., Costa D.C., Adshead G., Deahl M., Busatto G., Gacinovic S., Travis M., Pilowsky L., Ell P.J., Marks I.M., Kerwin R.W. Brain blood flow in anxiety disorders: OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET). Br J Psychiatry. 1997; 171:346-350. (Pubitemid 27441556)
72. Hull A.M. Neuroimaging findings in post-traumatic stress disorder: systematic review. Br J Psychiatry. 2002;181:102-110. (Pubitemid 34864490)
73. Cohen R.A., Grieve S., Hoth K.F., Paul R.H., Sweet L., Tate D., Gunstad J., Stroud L., McCaffery J., Hitsman B., Niaura R., Clark C.R., McFarlane A., Bryant R., Gordon E., Williams L.M. Early life stress and morphometry of the adult anterior cingulate cortex and caudate nuclei [published correction appears in Biol Psychiatry. 2006;60(9):1023]. Biol Psychiatry. 2006;59(10):975-982.
74. Looi J.C.L., Maller J.J., Pagani M., Högberg G., Lindberg O., Liberg B., Botes L., Engman E-L, Zhang Y., Svensson L., Wahlund L-O. Caudate volumes in public transportation workers exposed to trauma in the Stockholm train system. Psychiatry Res. 2009;171(2):138-143.
75. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., Hoyer D., Palacios J.M. Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 1994; 33(3-4):367-386.
76. Boschert U., Amara D.A., Segu L., Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 1994;58 (1):167-182.
77. Pranzatelli M.R., Durkin M.M., Farmer M. Plastic responses of neonatal 5-hydroxytryptamine1B receptors to 5,7-dihydroxytryptamine lesions mapped by quantitative autoradiography. Int J Dev Neurosci. 1996;14(5):621-629. (Pubitemid 26375485)
78. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci. 1986;6(12): 3474-3482.
79. Pellow S., Johnston A.L., File S.E. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol. 1987;39(11): 917-928. (Pubitemid 18048643)
80. B receptor mRNA levels in dorsal raphe nucleus: inverse association with anxiety behavior in the elevated plus maze. Pharmacol Biochem Behav. 2003;75(4):769-776.
81. 1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol. 2005;526(1-3):125-139.
82. Hoebel B.G., Avena N.M., Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol. 2007;7(6):617-627. (Pubitemid 350177561)
83. 1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl). 2011;213(2-3): 547-553.
84. Hu J., Henry S., Gallezot J-D, Ropchan J., Neumaier J.F., Potenza M.N., Sinha R., Krystal J.H., Huang Y., Ding Y-S, Carson R.E., Neumeister A. Serotonin 1B receptor imaging in alcohol dependence. Biol Psychiatry. 2010;67(9):800-803.
85. Chaouloff F., Berton O., Mormède P. Serotonin and stress. Neuropsychopharmacology. 1999;21(2)(suppl):28S-32S. (Pubitemid 29396468)
86. Dunn A.J. Stress-related changes in cerebral catecholamine and indoleamine metabolism: Lack of effect of adrenalectomy and corticosterone. J Neurochem. 1988; 51(2):406-412.
87. 2B receptors. Mol Pharmacol. 2007;71(6):1463-1474.
88. 1B-receptors in the primate brain. Synapse. 2010;64(7):573-577.